Pathologists across Singapore, Austria, Germany, Belgium and the UK adopt Philips Digital
Pathology Solutions to drive cutting-edge diagnostics
EINDHOVEN, Netherlands,
Sept. 8, 2015 /PRNewswire/ -- As the
number of trained pathologists decreases while the aging population
and complexity of cancer is on the rise, Royal Philips (NYSE: PHG,
AEX: PHIA) today announced the growing adoption of its Digital
Pathology Solutions by health systems across the globe who are
enhancing their operations. Through its IntelliSite Pathology
Solution*, Philips enables health care organizations to reinvent
the traditional histopathology workflow, enhance efficiency and
productivity, and improve the confidence in making diagnosis.
Photo - http://photos.prnewswire.com/prnh/20150908/264234
Photo - http://photos.prnewswire.com/prnh/20150908/264235
Through examination of patient tissue samples, pathology plays a
crucial role in the diagnosis, management and prevention of a
variety of diseases, including cancer. As health care cost and
quality pressures continue to mount, digital pathology can help
improve the efficiency and quality of cancer diagnostics. Several
high-volume and networked pathology institutions across the world
have implemented the Philips digital pathology platform, which
offers an integrated approach to improve workflows, enhance
collaboration capabilities to speed up consults, unify patient data
and enable a flexible growth path to get more information from
tumor tissue.
"Modern pathology labs are coming under continued pressure to
increase throughput and efficiency while improving quality," said
Russell Granzow, General Manager of
Philips Digital Pathology Solutions. "As the shift towards
personalized medicine requires pathology data that guides the right
therapy for the right patient at the right time, Philips is driving
the evolution toward digitized workflows to ensure pathologists are
empowered to meet industry demand."
- Supporting Archiving in Singapore
Singapore General Hospital (SGH), the flagship hospital of the
country's public health care system, recently implemented the
world's largest digital pathology installation in its diagnostic
laboratory. To handle its more than 50,000 pathology cases a year,
SGH will leverage more than 1.6 petabytes of disk storage and 1.6
petabytes of tape archiving storage to avoid the challenges of
storing glass tissue slides – like loss, breakage, degrading or
manual archiving errors – and reduce the physical space needed to
manage all of these records.
- Full Scale Installation in Belgium
The AZ Sint Jan in Brugge,
Belgium completed a full-scale
installation that is designed to accommodate full digital
histopathology diagnosis. Recognizing that a short transitional
process to digital would save a great deal in efficiency and costs,
the lead pathologist Dr. Van den
Berghe opted to avoid a gradual transitioning strategy by
coordinating a full digital implementation to benefit from this new
way of working.
- Providing Remote Diagnostic Services across Austria
In Austria two private pathology laboratories in
Hall in Tirol and St. Pölten provide diagnostic services for
hospitals and private medical centers across Austria. To speed up sample diagnosis and to
implement interactive consultation of experts for the patients, Dr.
Soleiman is creating an international network of pathologists by
transitioning to an entirely digital workflow with about 200,000
histology slides per year with the Philips IntelliSite
solution.
- Germany's Largest
Telemedicine Platform Goes Online
The "CCS Telehealth
Ostsachsen" platform is provided by a subsidiary of Dresden's
university clinic and T-Systems International. The European pilot
scheme offers a broad range of possibilities in networked medical
care and is intended to overcome former limitations. Incorporating
digital pathology, pathologists have the opportunity to analyze
digitally captured tissue samples and to digitally consult a
council of other specialists with the aim to improve patient
diagnosis.
- Expanding Teams through Virtualization in the
UK
Sheffield Teaching Hospitals (STH) NHS Foundation
Trust will partner with Hull and East Yorkshire Hospitals NHS
Trust to develop a service for remote digital reporting of
pathology cases. By addressing the long standing problem of a
shortage of histopathologists in the United Kingdom, this unique collaboration for
the UK enables the partners to offer their service to other
hospitals in the Yorkshire and
Humber region and beyond, and facilitates access to subspecialised
diagnostic histopathology service for all patients. The system is
designed to scale should more sites and pathology laboratories join
this collaboration.
Across the globe, leading institutions are leveraging Philips'
experience in clinical digital transformation to help pathology
laboratories make that next step in workflow improvement and
accelerate knowledge sharing between care providers.
For further information, please contact:
Hans Driessen
Philips Digital Pathology Solutions
+31 6 10 610 417
hans.driessen@philips.com
Steve Klink
Philips
Group Communications
+31 6 1088 8824
steve.klink@philips.com
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and
Lighting. Headquartered in the
Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately
108,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
* Philips IntelliSite Pathology Solution is CE marked for
primary diagnostics in the EU and Health Canada. In the U.S.,
Philips IntelliSite Pathology Solution is cleared by FDA for
diagnostic use in the evaluation of HER2 expression in breast
cancer and is offered for research use (RUO).